Mettler-Toledo International Inc. (NYSE:MTD) Given Average Rating of “Reduce” by Analysts

Mettler-Toledo International Inc. (NYSE:MTD) has received an average rating of “Reduce” from the eight analysts that are covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating on the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $1,363.75.

Several analysts have recently weighed in on MTD shares. Wells Fargo & Company assumed coverage on shares of Mettler-Toledo International in a report on Tuesday, August 27th. They issued an “equal weight” rating and a $1,400.00 target price on the stock. StockNews.com upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Thursday, July 11th. JPMorgan Chase & Co. raised their price target on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a report on Monday, August 5th. The Goldman Sachs Group upped their price objective on Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the stock a “neutral” rating in a report on Tuesday, July 9th. Finally, Stifel Nicolaus raised their target price on Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the company a “buy” rating in a report on Monday, August 5th.

Insider Activity

In other news, CFO Shawn Vadala sold 250 shares of the firm’s stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $1,401.00, for a total transaction of $350,250.00. Following the completion of the transaction, the chief financial officer now directly owns 4,914 shares of the company’s stock, valued at $6,884,514. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, insider Christian Magloth sold 1,000 shares of Mettler-Toledo International stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the completion of the sale, the insider now directly owns 734 shares in the company, valued at $1,044,459.98. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Shawn Vadala sold 250 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $1,401.00, for a total transaction of $350,250.00. Following the completion of the transaction, the chief financial officer now directly owns 4,914 shares of the company’s stock, valued at approximately $6,884,514. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

Several hedge funds and other institutional investors have recently bought and sold shares of MTD. EverSource Wealth Advisors LLC boosted its holdings in shares of Mettler-Toledo International by 8.0% during the first quarter. EverSource Wealth Advisors LLC now owns 95 shares of the medical instruments supplier’s stock worth $117,000 after purchasing an additional 7 shares during the last quarter. UMB Bank n.a. grew its holdings in Mettler-Toledo International by 6.6% in the 2nd quarter. UMB Bank n.a. now owns 113 shares of the medical instruments supplier’s stock valued at $158,000 after buying an additional 7 shares during the period. Bellevue Group AG increased its stake in shares of Mettler-Toledo International by 32.0% during the 1st quarter. Bellevue Group AG now owns 33 shares of the medical instruments supplier’s stock valued at $44,000 after acquiring an additional 8 shares during the last quarter. Massmutual Trust Co. FSB ADV increased its stake in shares of Mettler-Toledo International by 7.2% during the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 119 shares of the medical instruments supplier’s stock valued at $166,000 after acquiring an additional 8 shares during the last quarter. Finally, DT Investment Partners LLC boosted its position in shares of Mettler-Toledo International by 13.3% in the third quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier’s stock worth $102,000 after acquiring an additional 8 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Stock Performance

Shares of MTD opened at $1,291.75 on Friday. Mettler-Toledo International has a fifty-two week low of $953.28 and a fifty-two week high of $1,546.93. The firm has a 50-day simple moving average of $1,405.26 and a 200-day simple moving average of $1,393.58. The company has a market capitalization of $27.41 billion, a price-to-earnings ratio of 35.55, a price-to-earnings-growth ratio of 3.78 and a beta of 1.14.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 earnings per share for the quarter, beating the consensus estimate of $9.00 by $0.65. Mettler-Toledo International had a negative return on equity of 575.61% and a net margin of 20.95%. The company had revenue of $946.75 million for the quarter, compared to the consensus estimate of $929.13 million. During the same period last year, the business posted $10.19 EPS. The company’s revenue was down 3.6% on a year-over-year basis. Equities research analysts forecast that Mettler-Toledo International will post 40.34 EPS for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.